BRAIN Biotech AG
Common Stock · EUR · XETRA
Price
€3
Cap
€46.13M
Earnings
—
30d Trend
+9.9%
73% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 49×Macro 0.99 (−1%)=49
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
Potential value play — but fundamentals need strengthening
BRAIN47'S ASSESSMENT
I rate BRAIN Biotech AG at 49/100 — a MODERATE reading on the Brain47 Signal. The strongest factor is fundamentals at 75/100. I classify this as a speculative position with the strongest thesis on a long-term horizon.
PAST PERFORMANCE
1 MONTH
+9.0%
3 MONTHS
+14.6%
12 MONTHS
+39.2%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
Potential value play — but fundamentals need strengthening. Fundamentals (75) and Technical (61) are the primary strengths. I note an elevated risk profile — this warrants closer monitoring. Historical volatility is elevated at 73%. I classify this as a speculative position — elevated volatility at 73% and smaller market cap define the opportunity.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.